Cargando…

Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch

Daily steps could be a valuable indicator of real-world ambulation in Parkinson’s disease (PD). Nonetheless, no study to date has investigated the minimum number of days required to reliably estimate the average daily steps through commercial smartwatches in people with PD. Fifty-six patients were m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchini, Edoardo, Galli, Silvia, Alborghetti, Marika, De Carolis, Lanfranco, Zampogna, Alessandro, Hansen, Clint, Vuillerme, Nicolas, Suppa, Antonio, Pontieri, Francesco E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649244/
https://www.ncbi.nlm.nih.gov/pubmed/37960670
http://dx.doi.org/10.3390/s23218971
_version_ 1785135521864876032
author Bianchini, Edoardo
Galli, Silvia
Alborghetti, Marika
De Carolis, Lanfranco
Zampogna, Alessandro
Hansen, Clint
Vuillerme, Nicolas
Suppa, Antonio
Pontieri, Francesco E.
author_facet Bianchini, Edoardo
Galli, Silvia
Alborghetti, Marika
De Carolis, Lanfranco
Zampogna, Alessandro
Hansen, Clint
Vuillerme, Nicolas
Suppa, Antonio
Pontieri, Francesco E.
author_sort Bianchini, Edoardo
collection PubMed
description Daily steps could be a valuable indicator of real-world ambulation in Parkinson’s disease (PD). Nonetheless, no study to date has investigated the minimum number of days required to reliably estimate the average daily steps through commercial smartwatches in people with PD. Fifty-six patients were monitored through a commercial smartwatch for 5 consecutive days. The total daily steps for each day was recorded and the average daily steps was calculated as well as the working and weekend days average steps. The intraclass correlation coefficient (ICC) (3,k), standard error of measurement (SEM), Bland–Altman statistics, and minimum detectable change (MDC) were used to evaluate the reliability of the step count for every combination of 2–5 days. The threshold for acceptability was set at an ICC ≥ 0.8 with a lower bound of CI 95% ≥ 0.75 and a SAM < 10%. ANOVA and Mann–Whitney tests were used to compare steps across the days and between the working and weekend days, respectively. Four days were needed to achieve an acceptable reliability (ICC range: 0.84–0.90; SAM range: 7.8–9.4%). In addition, daily steps did not significantly differ across the days and between the working and weekend days. These findings could support the use of step count as a walking activity index and could be relevant to developing monitoring, preventive, and rehabilitation strategies for people with PD.
format Online
Article
Text
id pubmed-10649244
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106492442023-11-04 Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch Bianchini, Edoardo Galli, Silvia Alborghetti, Marika De Carolis, Lanfranco Zampogna, Alessandro Hansen, Clint Vuillerme, Nicolas Suppa, Antonio Pontieri, Francesco E. Sensors (Basel) Article Daily steps could be a valuable indicator of real-world ambulation in Parkinson’s disease (PD). Nonetheless, no study to date has investigated the minimum number of days required to reliably estimate the average daily steps through commercial smartwatches in people with PD. Fifty-six patients were monitored through a commercial smartwatch for 5 consecutive days. The total daily steps for each day was recorded and the average daily steps was calculated as well as the working and weekend days average steps. The intraclass correlation coefficient (ICC) (3,k), standard error of measurement (SEM), Bland–Altman statistics, and minimum detectable change (MDC) were used to evaluate the reliability of the step count for every combination of 2–5 days. The threshold for acceptability was set at an ICC ≥ 0.8 with a lower bound of CI 95% ≥ 0.75 and a SAM < 10%. ANOVA and Mann–Whitney tests were used to compare steps across the days and between the working and weekend days, respectively. Four days were needed to achieve an acceptable reliability (ICC range: 0.84–0.90; SAM range: 7.8–9.4%). In addition, daily steps did not significantly differ across the days and between the working and weekend days. These findings could support the use of step count as a walking activity index and could be relevant to developing monitoring, preventive, and rehabilitation strategies for people with PD. MDPI 2023-11-04 /pmc/articles/PMC10649244/ /pubmed/37960670 http://dx.doi.org/10.3390/s23218971 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bianchini, Edoardo
Galli, Silvia
Alborghetti, Marika
De Carolis, Lanfranco
Zampogna, Alessandro
Hansen, Clint
Vuillerme, Nicolas
Suppa, Antonio
Pontieri, Francesco E.
Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
title Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
title_full Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
title_fullStr Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
title_full_unstemmed Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
title_short Four Days Are Enough to Provide a Reliable Daily Step Count in Mild to Moderate Parkinson’s Disease through a Commercial Smartwatch
title_sort four days are enough to provide a reliable daily step count in mild to moderate parkinson’s disease through a commercial smartwatch
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649244/
https://www.ncbi.nlm.nih.gov/pubmed/37960670
http://dx.doi.org/10.3390/s23218971
work_keys_str_mv AT bianchiniedoardo fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT gallisilvia fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT alborghettimarika fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT decarolislanfranco fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT zampognaalessandro fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT hansenclint fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT vuillermenicolas fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT suppaantonio fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch
AT pontierifrancescoe fourdaysareenoughtoprovideareliabledailystepcountinmildtomoderateparkinsonsdiseasethroughacommercialsmartwatch